Martinez-Kinader B, Lipford G B, Wagner H, Heeg K
Institute for Medical Microbiology and Hygiene, Technical University of Munich, Germany.
Immunology. 1995 Oct;86(2):287-95.
Immunization with exogenous proteins usually fails to immunize CD8+ T cells in vivo. Here we report that chicken ovalbumin (OVA) denatured by heat or sodium dodecyl sulphate (SDS) effectively induced CD8+ cytolytic T cells in vivo. The cytolytic T-lymphocyte (CTL) population generated recognized syngeneic target cells pulsed with the immunodominant OVA peptide (257-264) or transfected with the OVA protein-encoding gene. To analyse the mechanisms of how denatured OVA enters the class I-restricted pathway of antigen presentation, we took advantage of the fact that denatured OVA sensitizes target cells in vitro for lysis by OVA-specific CTL. We found that neither inhibition of protein synthesis (by cycloheximide) nor blocking of transport via the Golgi apparatus (by brefeldin A) interfered with the class I-restricted presentation of denatured OVA in vitro. In addition, transporter associated with antigen presentation (TAP)-dependent transport into the endoplasmic reticulum (ER) was not required for effective presentation, as TAP-deficient cells (RMA-S) could be sensitized effectively by denatured OVA for recognition by class I-restricted CTL. In contrast, class I-restricted presentation of denatured OVA was sensitive to lysosomotropic agents (NH4Cl, vinblastine and leupeptin), indicating that endosomal-like compartments are involved in the presentation of denatured OVA. Sensitization was inhibited at low temperature, yet took place in the presence of sucrose and in the absence of K+, indicating that denatured OVA enters the cell via fluid-phase endocytosis. Hence the results provide further evidence for an alternative class I-restricted pathway of antigen presentation for exogenous proteins. As that pathway seems to be effective in vivo, it offers a new and effective way of vaccination of CD8+ CTL.
用外源性蛋白质进行免疫通常无法在体内使CD8⁺ T细胞产生免疫反应。在此我们报告,经加热或十二烷基硫酸钠(SDS)变性的鸡卵清蛋白(OVA)能在体内有效诱导CD8⁺ 溶细胞性T细胞。所产生的溶细胞性T淋巴细胞(CTL)群体能够识别用免疫显性OVA肽(257 - 264)脉冲处理或转染了OVA蛋白编码基因的同基因靶细胞。为了分析变性OVA进入I类限制性抗原呈递途径的机制,我们利用了变性OVA在体外使靶细胞对OVA特异性CTL的裂解敏感这一事实。我们发现,无论是通过环己酰亚胺抑制蛋白质合成,还是通过布雷菲德菌素A阻断经高尔基体的转运,都不会干扰体外变性OVA的I类限制性呈递。此外,有效呈递并不需要与抗原呈递相关的转运体(TAP)依赖的向内质网(ER)的转运,因为TAP缺陷细胞(RMA - S)可被变性OVA有效致敏,以供I类限制性CTL识别。相反,变性OVA的I类限制性呈递对溶酶体促渗剂(氯化铵、长春碱和亮抑酶肽)敏感,表明类似内体的区室参与了变性OVA的呈递。致敏在低温下受到抑制,但在有蔗糖存在且无钾离子的情况下仍会发生,这表明变性OVA通过液相内吞作用进入细胞。因此,这些结果为外源性蛋白质的另一种I类限制性抗原呈递途径提供了进一步的证据。由于该途径在体内似乎是有效的,它为CD8⁺ CTL的疫苗接种提供了一种新的有效方法。